{"id":"https://openalex.org/W4244423484","doi":"https://doi.org/10.1016/s0099-5428(08)60669-3","title":"Clioquinol","display_name":"Clioquinol","publication_year":1990,"publication_date":"1990-01-01","ids":{"openalex":"https://openalex.org/W4244423484","doi":"https://doi.org/10.1016/s0099-5428(08)60669-3"},"language":"en","primary_location":{"id":"doi:10.1016/s0099-5428(08)60669-3","doi":"https://doi.org/10.1016/s0099-5428(08)60669-3","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0099-5428(08)60669-3","pdf_url":null,"source":{"id":"https://openalex.org/S4210172737","display_name":"Analytical profiles of drug substances","issn_l":"0099-5428","issn":["0099-5428","2163-5846"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"book series"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Analytical Profiles of Drug Substances","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W4233682939","display_name":null},"type":"book-chapter","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056245930","display_name":"Gandharva Padmanabhan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gandharva Padmanabhan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051080001","display_name":"Ingrid Becue","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ingrid Becue","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5103405847","display_name":"James Barclay Smith","orcid":"https://orcid.org/0009-0005-6967-1632","observed_orcids":["https://orcid.org/0009-0005-6967-1632"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James B. Smith","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":24,"citation_normalized_percentile":{"value":0.58083832,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":null,"issue":null,"first_page":"57","last_page":"90"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.9384999871253967,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.9384999871253967,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12526","display_name":"Antimicrobial agents and applications","score":0.01679999940097332,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.007000000216066837,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clioquinol","display_name":"clioquinol","score":0.9710000157356262},{"id":"https://openalex.org/keywords/drug-substance-characterization","display_name":"drug substance characterization","score":0.5389999747276306},{"id":"https://openalex.org/keywords/chemical-purity","display_name":"chemical purity","score":0.32100000977516174},{"id":"https://openalex.org/keywords/impurity-profiling","display_name":"impurity profiling","score":0.5630000233650208}],"concepts":[{"id":"https://openalex.org/C2776785578","wikidata":"https://www.wikidata.org/wiki/Q5134338","display_name":"Clioquinol","level":2,"score":0.6336278915405273},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.21125024557113647},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.06900143623352051}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s0099-5428(08)60669-3","doi":"https://doi.org/10.1016/s0099-5428(08)60669-3","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0099-5428(08)60669-3","pdf_url":null,"source":{"id":"https://openalex.org/S4210172737","display_name":"Analytical profiles of drug substances","issn_l":"0099-5428","issn":["0099-5428","2163-5846"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"book series"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Analytical Profiles of Drug Substances","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1533944312","https://openalex.org/W1996003066","https://openalex.org/W1997305571","https://openalex.org/W2011345069","https://openalex.org/W2027257465","https://openalex.org/W2037090411","https://openalex.org/W2038048392","https://openalex.org/W2046540905","https://openalex.org/W2071931112","https://openalex.org/W2075763971","https://openalex.org/W2085295988","https://openalex.org/W2107875591","https://openalex.org/W2121132503","https://openalex.org/W2141514319","https://openalex.org/W2145430534","https://openalex.org/W2147486412","https://openalex.org/W2150497621","https://openalex.org/W2417216447","https://openalex.org/W4206616799"],"related_works":["https://openalex.org/W4240204865","https://openalex.org/W4254692273","https://openalex.org/W4241530784","https://openalex.org/W4300223379","https://openalex.org/W4300718868","https://openalex.org/W2438567664","https://openalex.org/W4293190028","https://openalex.org/W4240024300","https://openalex.org/W4252309344","https://openalex.org/W4253012749"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2022-05-12T00:00:00"}